Resectable Pancreatic Ductal Adenocarcinoma Clinical Trials in Atlanta, Georgia
3 recruitingAtlanta, Georgia
Showing 1–3 of 3 trials
Recruiting
Phase 2
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
Stage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Resectable Pancreatic Adenocarcinoma+2 more
Emory University36 enrolled1 locationNCT06423326
Recruiting
Phase 3
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Stage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8+1 more
NRG Oncology356 enrolled279 locationsNCT06958328
Recruiting
Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
Borderline Resectable Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8Resectable Pancreatic Ductal Adenocarcinoma
Emory University87 enrolled1 locationNCT06595160